{
  "id": 6928,
  "language": "english",
  "hallucination": "yes",
  "ground_truth_source": "Original_text",
  "dialogue_data": {
    "dialogue_metadata": {
      "inferred_relationship": "Podcast co-hosts",
      "inferred_vibe": "Informative and concerned"
    },
    "dialogue_turns": [
      {
        "speaker": "Host_B",
        "text": "So, um, it's pretty wild to think about diseases like TB, which, like, we totally eradicated years ago, right?",
        "tts_text": "So, um, it's pretty wild to think about diseases like T B, which, like, we totally eradicated years ago, right?",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "TB is the worlds deadliest infection, and it has been with us for a very long time.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Uh, wait, what? Eradicated? Are you, um, seriously suggesting that?",
        "tts_text": "Uh, wait, what? Eradicated? Are you, um, seriously suggesting that?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "Well, I mean, you'd think, right? But no, uh, it's actually the world's deadliest infection. Millions have died.",
        "tts_text": "Well, I mean, you'd think, right? But no, uh, it's actually the world's deadliest infection. Millions have died.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "TB is the worlds deadliest infection... The 250 million people who have been infected since 1993 and the millions who have died deserved better.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Millions? Come on. But we've had, like, twenty-five years of effort. We should have, um, fixed it by now.",
        "tts_text": "Millions? Come on. But we've had, like, twenty-five years of effort. We should have, um, fixed it by now.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "But while leaders generally agree on the need to invest in solutions, we have surprisingly few TB medicines to show for our quarter-century of effort.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "You'd think. But it's been with us for five thousand years. And, uh, it killed about 1.8 million people in 2017 alone.",
        "tts_text": "You'd think. But it's been with us for five thousand years. And, uh, it killed about one point eight million people in twenty seventeen alone.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "Researchers theorize that humans first acquired TB in Africa about 5,000 years ago... Today, TB is among the worlds leading causes of death, killing approximately 1.6 million people in 2017",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Okay, but, um, what about all these modern medicines? They're supposed to be, like, super effective, aren't they?",
        "tts_text": "Okay, but, um, what about all these modern medicines? They're supposed to be, like, super effective, aren't they?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "The effectiveness is declining. Drug-resistant strains are, uh, becoming more virulent. Some are even airborne for significantly longer periods now.",
        "tts_text": "The effectiveness is declining. Drug-resistant strains are, uh, becoming more virulent. Some are even airborne for significantly longer periods now.",
        "check_worthy": true,
        "factual_label": "NEI",
        "evidence_snippet": "But the effectiveness of TB treatments is declining, raising concerns that drug-resistant strains are becoming more virulent.",
        "confidence": 0.9,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Airborne longer? So, it's, like, just a medical problem then? Nothing, um, bigger than that?",
        "tts_text": "Airborne longer? So, it's, like, just a medical problem then? Nothing, um, bigger than that?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "It's not purely medical. It, um, perpetuates poverty. Patients spend up to half their income on medicines.",
        "tts_text": "It's not purely medical. It, um, perpetuates poverty. Patients spend up to half their income on medicines.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Given its prevalence and seriousness, TB is not purely a medical problem. The disease perpetuates poverty in developing countries, because patients and their families must routinely spend up to half of their income buying medicines and managing care.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Half? And, uh, it still doesn't always yield results, with these new strains? That's, like, insane.",
        "tts_text": "Half? And, uh, it still doesn't always yield results, with these new strains? That's, like, insane.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "And yet, with drug-resistant forms of TB spreading, these expenditures do not always yield results.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "It is. And the economic cost? Drug-resistant TB could, uh, hit the global economy for over $20 trillion by 2050.",
        "tts_text": "It is. And the economic cost? Drug-resistant T B could, uh, hit the global economy for over twenty dollars trillion by twenty fifty.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "By 2050, drugresistant TB could cost the global economy as much as $16.7 trillion in medical expenses and lost wages",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Twenty trillion? You're, um, making that up. So why isn't there, like, proper R&D funding if it's that serious?",
        "tts_text": "Twenty trillion? You're, um, making that up. So why isn't there, like, proper R&D funding if it's that serious?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "There's an annual funding deficit of over $1.3 billion for R&D. Lack of market incentives for the pharmaceutical industry, mostly.",
        "tts_text": "There's an annual funding deficit of over one point three dollars billion for R&D. Lack of market incentives for the pharmaceutical industry, mostly.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "According to the World Health Organization, the annual funding deficit for TB research and development is more than $1.3 billion, a shortfall that is exacerbated by a lack of market incentives within the pharmaceutical industry.",
        "confidence": 1.0,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "Ah, so it's, um, the intellectual property rights then, isn't it? That's what's stopping everything.",
        "tts_text": "Ah, so it's, um, the intellectual property rights then, isn't it? That's what's stopping everything.",
        "check_worthy": true,
        "factual_label": "False",
        "evidence_snippet": "But we cannot simply ignore the role that intellectual property plays in the creation of new treatments.",
        "confidence": 0.8,
        "priority": "high"
      },
      {
        "speaker": "Host_B",
        "text": "That's part of the quandary. How do we guarantee access, especially for the poorest, while still, uh, funding R&D? There are issues with generic drugs too.",
        "tts_text": "That's part of the quandary. How do we guarantee access, especially for the poorest, while still, uh, funding R&D? There are issues with generic drugs too.",
        "check_worthy": true,
        "factual_label": "NEI",
        "evidence_snippet": "how can we guarantee access to medications especially for the poorest patients while maintaining funding streams for pharmaceutical R&D?",
        "confidence": 0.9,
        "priority": "high"
      },
      {
        "speaker": "Host_A",
        "text": "So, like, world leaders commit to 'bold solutions' but then it's just, um, more talking? No actual progress?",
        "tts_text": "So, like, world leaders commit to 'bold solutions' but then it's just, um, more talking? No actual progress?",
        "check_worthy": false,
        "factual_label": "NEI",
        "evidence_snippet": ""
      },
      {
        "speaker": "Host_B",
        "text": "They did agree. But, uh, last year, 3.6 million people infected with TB couldn't access treatment. It needs a massive increase in R&D and collaboration.",
        "tts_text": "They did agree. But, uh, last year, three point six million people infected with T B couldn't access treatment. It needs a massive increase in R&D and collaboration.",
        "check_worthy": true,
        "factual_label": "True",
        "evidence_snippet": "Last year, an estimated 3.6 million people infected with TB were unable to access treatment, a staggering gap in coverage that must be quickly closed.",
        "confidence": 1.0,
        "priority": "high"
      }
    ]
  },
  "batch_index": 3
}